Efficiency of recombinant human TNF in human cancer therapy.

Abstract

Recombinant human tumour necrosis factor (TNF) has a selective effect on angiogenic vessels in tumours. Given that it induces vasoplegia, its clinical use has been limited to administration through isolated limb perfusion (ILP) for regionally advanced melanomas and soft tissue sarcomas of the limbs. When combined with the alkylating agent melphalan, a… (More)

19 Figures and Tables

Topics

  • Presentations referencing similar topics